Pharma Equity Group A/S (PEG.CO)

DKK 0.08

(-12.45%)

Revenue Summary of Pharma Equity Group A/S

  • Pharma Equity Group A/S's latest annual revenue in 2023 was - DKK , down 0.0% from previous year.
  • Pharma Equity Group A/S's latest quarterly revenue in 2024 Q2 was - DKK , down 0.0% from previous quarter.
  • Pharma Equity Group A/S reported a annual revenue of - DKK in annual revenue 2022, down 0.0% from previous year.
  • Pharma Equity Group A/S reported a annual revenue of - DKK in annual revenue 2021, down 0.0% from previous year.
  • Pharma Equity Group A/S reported a quarterly revenue of - DKK for 2024 Q2, down 0.0% from previous quarter.
  • Pharma Equity Group A/S reported a quarterly revenue of - DKK for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Pharma Equity Group A/S (2023 - 2008)

Historical Annual Revenue of Pharma Equity Group A/S (2023 - 2008)

Year Revenue Revenue Growth
2023 - DKK 0.0%
2022 - DKK 0.0%
2021 - DKK 0.0%
2020 - DKK 0.0%
2019 - DKK 0.0%
2018 - DKK 0.0%
2017 - DKK -100.0%
2016 1.05 Million DKK 70.0%
2015 620 Thousand DKK 0.0%
2014 - DKK 0.0%
2013 - DKK -100.0%
2012 13.25 Million DKK -14.43%
2011 15.48 Million DKK 2895.36%
2010 517 Thousand DKK 0.0%
2009 - DKK 0.0%
2008 - DKK 0.0%

Peer Revenue Comparison of Pharma Equity Group A/S

Name Revenue Revenue Difference
ALK-Abelló A/S 4.82 Billion DKK 100.0%
Bavarian Nordic A/S 7.05 Billion DKK 100.0%
Genmab A/S 16.47 Billion DKK 100.0%
Gubra A/S 205 Million DKK 100.0%
Novo Nordisk A/S 232.26 Billion DKK 100.0%
Orphazyme A/S - DKK NaN%
Zealand Pharma A/S 342.78 Million DKK 100.0%